Pasithea Therapeutics Corp. has received IND clearance by the FDA to evaluate PAS-004, a small-molecule allosteric inhibitor of MEK 1/2, in patients with MAPK pathway-driven advanced solid tumors with ...
ABM Therapeutics Inc. presented a novel small-molecule, ATP-uncompetitive, phosphorylated MEK (pMEK) inhibitor – ABM-4095 – that potently prevents phosphorylation of MEK by RAF with moderate ...
Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced it has selected an optimized Erk inhibitor molecule for development, thus achieving another important milestone in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results